@RevealGenomics Profile picture

REVEAL GENOMICS

@RevealGenomics

We want to change how biomarkers are routinely used in oncology. #HER2DX #DNADX #TNBCDX

Similar User
Dana-Farber’s Breast Oncology Center photo

@DFCI_BreastOnc

Andres Cervantes photo

@AndresC27622123

Aleix Prat #PrecisionOncology photo

@prat_aleix

Tomás Pascual photo

@TomasPascualMD

Evandro de Azambuja, MD, PhD photo

@E_de_Azambuja

Vall d’Hebron Institute of Oncology (VHIO) photo

@VHIO

Sonia Pernas photo

@SoniaPernas

EORTC Breast Cancer Group photo

@EORTC_BCG

Kevin Punie photo

@kevinpunie

Francesco Schettini, MD PhD 🇮🇹🇪🇸🇪🇺 photo

@FrancescoSche20

Patricia Villagrasa photo

@patri0608

Giampaolo Bianchini photo

@BianchiniGP

Maria Vidal photo

@MVidalMD

Pablo Tolosa Ortega photo

@OrtegaTolosa

Meritxell Bellet photo

@BelletMeritxell

REVEAL GENOMICS Reposted

✨ New in @ESMO_Open: Expert opinion on the #HER2DX genomic test! 🧬 The #HER2DX test personalizes treatment for patients with HER2+ breast cancer by analyzing genomic and clinical factors. •It provides three scores: risk, likelihood of pathological complete response (pCR),…

Tweet Image 1

Remarkable Milestones! 🎉 #HER2DX is on a roll, continuously adding valuable clinical evidence data! Here’s everything we’ve achieved so far—and we’re just getting started! Stay tuned for more advancements! 🚀 #HER2+ #precisiononology #breastcancer More: ow.ly/YKZm50TV7QN


El nostre CSO i cofundador @prat_aleix parla a @SEGREcom sobre #TNBCDX i el càncer de mama triple negatiu, destacant la importància d’ajudes com la @BecaMartaS Llegeix l’article aquí (en català): ow.ly/F78i50TP1JB


On this day, we reaffirm our commitment to advancing research, innovation, and #precisiononcology. Every breakthrough brings us closer to better outcomes for #patients. #PrecisionOncology #Innovation #BreastCancerAwarenessMonth #HER2DX #DNADX #TNBCDX


REVEAL GENOMICS Reposted

The @DefinitiveTrial project has kicked off with its first SIV! 🏥

Tweet Image 1

REVEAL GENOMICS Reposted
Tweet Image 1

AI-Driven Genomic Test Shows Promise in De-Escalating Neoadjuvant TNBC Therapy genomeweb.com/cancer/ai-driv…



🎉 Celebrating 4 amazing years today! This milestone is just the beginning, thanks to our visionary leadership, committed team, and everyone who trusts us. We are dedicated to transforming cancer care to benefit patients. 🚀 #breastcancer #HER2DX #DNADX #TNBCDX

Tweet Image 1

REVEAL GENOMICS Reposted

Gene signatures have revolutionized treatment for HR+ eBC. Could they also refine treatment for more aggressive subtypes? Intriguing data of TNBC-DX from a pooled analysis of 418 patients treated with neoadjuvant taxane-based chemo. #ESMOAmbassadors #ESMO24

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

REVEAL GENOMICS Reposted

🎯 We need strategies to personalize TNBC therapy. This presentation RE: TNBC-DX is exciting #ESMO24

Tweet Image 1
Tweet Image 2

REVEAL GENOMICS Reposted

TNBCDX: assay to predict pCR and DFS Data presented to look at validation (ADAPT-TN, and MMJ-CAR-2014 studies), n=418 pCR score associated with pCR OR 1.34 (independent of TIL) Low Risk score iDFS 89.9% vs High risk iDFS 69.4% @OncoAlert #ESMO24

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Conclusions from Dr. Miguel Martin's presentation on #TNBCDX, the test that will transform the treatment landscape for Triple-Negative #breastcancer #precisiononcology #esmo24 #ESMO2024

Tweet Image 1

REVEAL GENOMICS Reposted

Back to the future TNBC-DX looks forward to identity new possibilities to select therapy and development strategies to improve outcomes in TNBC #breastcancer #ESMO2024 @OncoAlert @prat_aleix @RevealGenomics

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

#TNBCDX is making an impact at #ESMO24 💡 The first genomic test for early-stage triple-negative #breastcancer shows a strong association with pCR, DDFS, and OS. Dr. Miguel Martin is presenting now. #precisiononcology More info: ow.ly/3Ba450Tnram

Tweet Image 1

REVEAL GENOMICS Reposted

🎉 Excited to share our latest review in Nature Reviews Clinical Oncology! 🎉 @NatRevClinOncol 📖 We dive into the latest on dual #HER2 inhibition in #BreastCancer—exploring synergy, patient selection, and resistance. 🔬💥 Big steps forward in personalized treatment for…

Tweet Image 1

We made it! 💫 Join us for the *Mini Oral session* on TNBCDX the first genomic test in early-stage triple-negative #breastcancer. 🗓 September 14th 🕙 10:50 - 10:55 📍 Barcelona Auditorium. 🗣️ Speaker: Dr Miguel Martin Jimenez #ESMO2024 #precisiononcology Don’t miss it!

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.